Announced Tue, 30 Jun · 17:56 IST
Aarti Pharmalabs inaugurates new 3600 TPA manufacturing block at Tarapur
Compliance View source PDF
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.3%1-day move
₹679.85
prior close
₹684.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.7+0.4+0.0+3.3+3.9+3.4+2.9+0.6+4.4-1.2———
Up moveDown movePending
AI summary
Aarti Pharmalabs has inaugurated a new manufacturing block at its Tarapur Unit 5 in Maharashtra. The facility adds 3600 TPA capacity for Xanthine derivatives, taking total capacity to 9600 TPA. The company says this places it among the top 3 Xanthine derivatives makers globally. Trial production has started, with full ramp-up expected over the next few quarters.
Likely market impact
Capacity expansion strengthens global ranking in Xanthine derivatives; positive signal for long-term growth and customer wins.